Comparing Aranesp vs Mircera
Aranesp (darbepoetin alfa) | Mircera (epoetin beta-methoxy polyethylene glycol) |
|
---|
Aranesp (darbepoetin alfa) | Mircera (epoetin beta-methoxy polyethylene glycol) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia - Chemotherapy Induced. Aranesp may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease. Mircera may also be used for purposes not listed in this medication guide. |
Related suggestions Anemia Due to Chronic Kidney Disease
Popular comparisons
|
|||||||
More about Aranesp (darbepoetin alfa) | More about Mircera (epoetin beta-methoxy polyethylene glycol) | ||||||||
Ratings & Reviews | |||||||||
Aranesp has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Mircera has an average rating of 1.8 out of 10 from a total of 4 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 75% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Aranesp side effects |
View all Mircera side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Mircera prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
49 hours |
206 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 21 drugs are known to interact with Aranesp:
|
A total of 23 drugs are known to interact with Mircera:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
September 17, 2001 |
November 14, 2007 |
||||||||
WADA Class View classifications | |||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.